Summary
Advanced Life Sciences Holdings, Inc. (Advanced Life Sciences) engages in the discovery, development, and commercialization of drugs in the areas of infectious disease, inflammation, and oncology. The company develops various clinical and preclinical product candidates for the treatment of respiratory tract infections, human immunodeficiency virus, acute respiratory distress syndrome, and cancer. The product portfolio of company includes Restanza (cethromycin) used to treat pneumonia, anthrax, plague and tularemia; ALS-357 used to treat metastatic melanoma and ALS-886 used in the treatment of inflammation-related tissue damage. FDA awarded Orphan drug designation to the company's Restanza, once daily oral antibiotic, for the prophylactic treatment of plague and tularemia. The company reported positive results from animal study of Restanza. The company is headquartered in Illinois, the US.
Advanced Life Sciences Holdings, Inc. (ADLS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Breakfast And Cereal Industry in the United Kingdom
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Advanced Life Sciences Holdings, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 4
Advanced Life Sciences Holdings, Inc., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 5
Advanced Life Sciences Holdings, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 6
Advanced Life Sciences Holdings, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 7
Advanced Life Sciences Holdings, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 8
Advanced Life Sciences Holdings, Inc., Pharmaceuticals & Healthcare, Deal Details 9
Partnerships 9
Advanced Life Sciences Enters Into Co-Development Agreement With Walter Reed Army Institute 9
Advanced Life Sciences Enters Into Co-Development Agreement With The University of British Columbia 11
Advanced Life Sciences Enters Into An Agreement With Wyeth 12
Equity Offering 14
Advanced Life Sciences Holdings Completes Private Placement Of $0.2 Million 14
Advanced Life Sciences Holdings Raises $1.6 Million Upon Exercise of Warrants 16
Advanced Life Sciences Completes Registered Direct Offering Of $1.6 Million 17
Advanced Life Sciences Completes Equity Offering Of $0.5 Million 19
Advanced Life Sciences Holdings Completes Private Placement Of $3.9 Million 20
Advanced Life Sciences Completes Private Placement Of $2 Million 22
Advanced Life Sciences Holdings Completes Private Placement Of $1.71 Million 23
Advanced Life Sciences Completes Private Placement Of $20 Million 24
Advanced Life Sciences Holdings, Inc. - Key Competitors 26
Key Employees 27
Locations And Subsidiaries 28
Head Office 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29
List of Tables
Advanced Life Sciences Holdings, Inc., Pharmaceuticals & Healthcare, Key Facts, 2010 1
Advanced Life Sciences Holdings, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 1
Advanced Life Sciences Holdings, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 1
Advanced Life Sciences Holdings, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 1
Advanced Life Sciences Holdings, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 4
Advanced Life Sciences Holdings, Inc., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 5
Advanced Life Sciences Holdings, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 6
Advanced Life Sciences Holdings, Inc., Deals By Therapy Area, 2007 to YTD 2013 7
Advanced Life Sciences Holdings, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 8
Advanced Life Sciences Enters Into Co-Development Agreement With Walter Reed Army Institute 9
Advanced Life Sciences Enters Into Co-Development Agreement With The University of British Columbia 11
Advanced Life Sciences Enters Into An Agreement With Wyeth 12
Advanced Life Sciences Holdings Completes Private Placement Of $0.2 Million 14
Advanced Life Sciences Holdings Raises $1.6 Million Upon Exercise of Warrants 16
Advanced Life Sciences Completes Registered Direct Offering Of $1.6 Million 17
Advanced Life Sciences Completes Equity Offering Of $0.5 Million 19
Advanced Life Sciences Holdings Completes Private Placement Of $3.9 Million 20
Advanced Life Sciences Completes Private Placement Of $2 Million 22
Advanced Life Sciences Holdings Completes Private Placement Of $1.71 Million 23
Advanced Life Sciences Completes Private Placement Of $20 Million 24
Advanced Life Sciences Holdings, Inc., Key Competitors 26
Advanced Life Sciences Holdings, Inc., Key Employees 27
List of Figures
Advanced Life Sciences Holdings, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013 1
Advanced Life Sciences Holdings, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 4
Advanced Life Sciences Holdings, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013 5
Advanced Life Sciences Holdings, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 6
Advanced Life Sciences Holdings, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 7
